STIMULATION OF ER+ BREAST-CANCER CELLS PRIOR TO ADMINISTRATION OF CELL-CYCLE-SPECIFIC CHEMOTHERAPY

被引：0
|
作者：
KIMLER, BF
FABIAN, C
PARK, CH
机构：
[1] UNIV KANSAS,MED CTR,DEPT RADIAT THERAPY,KANSAS CITY,KS 66103
[2] UNIV KANSAS,MED CTR,DEPT MED,KANSAS CITY,KS 66103
来源：
CELL AND TISSUE KINETICS | 1983年 / 16卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：609 / 609
页数：1
相关论文
共 50 条
  • [41] TRIM29 Functions as a Tumor Suppressor in Nontumorigenic Breast Cells and Invasive ER+ Breast Cancer
    Liu, Jin
    Welm, Bryan
    Boucher, Ken M.
    Ebbert, Mark T. W.
    Bernard, Philip S.
    AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (02): : 839 - 847
  • [42] Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2-breast cancer?
    Groheux, David
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1571 - 1573
  • [43] Gene expression signatures as a response predictor to preoperative doxorubicine/cyclophosphamide (AC) chemotherapy in ER+ breast cancer
    Lee, Eun Sook
    Kwon, Soim
    Kang, Hio Chung
    Park, Jae-Gahb
    Kim, Il-Jin
    Kwon, Youngmee
    Ro, Jungsil
    Kang, Han-Sung
    CANCER RESEARCH, 2006, 66 (08)
  • [44] MODERN CHEMOTHERAPY USE AMONG YOUNG WOMEN WITH EARLYSTAGE ER+/HER2-BREAST CANCER
    Poorvu, Philip
    Gelber, Shari
    Rosenberg, Shoshana
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Partridge, Ann
    BREAST, 2018, 41 : S18 - S18
  • [45] Is 18FDG uptake useful to decide on chemotherapy in ER+/HER2- breast cancer?
    David Groheux
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1571 - 1573
  • [46] APPLICATION OF COMBINED CHEMOTHERAPY INCLUDING ADRIABLASTIN ADMINISTRATION FOR TREATMENT OF ADVANCED BREAST-CANCER
    DEMENTEVA, NP
    ASS, NY
    LIPOVICH, MM
    VOPROSY ONKOLOGII, 1981, 27 (05) : 10 - 13
  • [47] CYCLIN GENES AND CELL-CYCLE CONTROL IN BREAST-CANCER
    SUTHERLAND, RL
    WATTS, CKW
    MUSGROVE, EA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 225 - 225
  • [48] AGGRESSIVE CHEMOTHERAPY FOR ESTROGEN-RECEPTOR (ER) NEGATIVE METASTATIC BREAST-CANCER (MBC)
    LIVINGSTON, R
    FABIAN, C
    RIVKIN, S
    VAUGHN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 142 - 142
  • [49] INFLUENCE OF CULTURE CONDITIONS ON THE ESTROGENIC CELL-GROWTH STIMULATION OF HUMAN BREAST-CANCER CELLS
    RUEDL, C
    CAPPELLETTI, V
    CORADINI, D
    GRANATA, G
    DIFRONZO, G
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (02): : 195 - 200
  • [50] TENIPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL IN PATIENTS WITH NO PRIOR CHEMOTHERAPY
    NIELSEN, D
    BOAS, J
    ENGELHOLM, SA
    HANSEN, OP
    DOMBERNOWSKY, P
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 377 - 378
12345